GLG Pharma Overview

  • Founded
  • 2009
Founded
  • Status
  • Public
  • Employees
  • 9
Employees
  • Stock Symbol
  • GLG
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $0.15
  • (As of Monday Closing)

GLG Pharma General Information

Description

GLG Pharma SA is a Polish company that operates in the biotechnology industry. It develops, manufactures and sells pharmaceutical products based on STAT3 inhibitors technology. Its flagship project is the development of targeted therapy for TNBC (triple negative breast cancer) and the development of immunochemical based tests for rapid diagnosis of TNBC cancer.

Contact Information

Formerly Known As
M10 SA
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Stock Exchange
WAR
Primary Office
  • Ul. Leszczynskiego 4 lok. 25
  • Wroclaw, 50-078
  • Poland
+48 71 000 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

GLG Pharma Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.15 $0.15 $0.13 - $0.83 $1.33M 8.8M 2.28K -$0.04

GLG Pharma Financials Summary

In Thousands,
USD
TTM 30-Sep-2018 FY 2017 31-Dec-2017 FY 2016 31-Dec-2016 FY 2015 31-Dec-2015
EV 4,605 6,271 1,724 2,308
Revenue 0 0 0 5
EBITDA (292) (216) (94) (46)
Net Income (292) (220) (98) (47)
Total Assets 4,770 4,578 3,264 3,453
Total Debt 100 37 112 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

GLG Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore GLG Pharma‘s full profile, request access.

Request a free trial

GLG Pharma Executive Team (4)

Name Title Board Seat Contact Info
Hector Gomez Ph.D Chief Executive Officer & Vice President of the Management Board
Sunanda Singh MD Director of Cancer Immunology
Michael Lovell Ph.D Vice President
John Whalen MD Chief Medical Officer
To view GLG Pharma’s complete executive team members history, request access »

GLG Pharma Board Members (2)

Name Representing Role Since
000000 00000 00.0 GLG Pharma Chief Executive Officer & Vice President of the Management Board 000 0000
0000000 0000000 GLG Pharma President of the Management Board 000 0000
To view GLG Pharma’s complete board members history, request access »

GLG Pharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GLG Pharma Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore GLG Pharma‘s full profile, request access.

Request a free trial

GLG Pharma Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 00000000 09-Aug-2018 00000 0000000 Drug Discovery 0000000 0000000
To view GLG Pharma’s complete investments history, request access »